UN-EM is a company created to advise Universities and Technological Centers to transfer research results to the market. The staff is specialized in technologies valuation, boosting entrepreneurship and the creation of Spin-Off companies. UN-EM facilitate the commercial exploitation of scientific results. The company is based on knowledge and methodologies which allows break down geographical barriers, with customers in Spain and Latin America.

  Experienced Director of Global Strategic Program and Portfolio Management with a demonstrated background in biotechnology industry with several products taken from early development to commercialization. Passionate and skilled in strategy, team management, with strong interpersonal skills fostering customer happiness. MBA graduate with major in entrepreneurship. Private Investor and Board Member at Qubiotech Health Intelligence and ChemoSapiens

Manager with 20 years of total, national and international, experience. Computer Engineer and MBA from the EOI. Native Spanish, good level of English (Title Trinity GESE 8), Portuguese and Galician. Significant experience in business development, leading own and third-party projects. Managing P&L, clients, budgets and people. I have developed this tasks during these last 8 years as General Manager, as well as 12 years in different manager positions in business and technology consulting, technical department management and people management.

Manager with 20 years of total, national and international, experience. Computer Engineer and MBA from the EOI. Native Spanish, good level of English (Title Trinity GESE 8), Portuguese and Galician. Significant experience in business development, leading own and third-party projects. Managing P&L, clients, budgets and people. I have developed this tasks during these last 8 years as General Manager, as well as 12 years in different manager positions in business and technology consulting, technical department management and people management.

Experienced Director of Global Strategic Program and Portfolio Management with a demonstrated background in biotechnology industry with several products taken from early development to commercialization. Passionate and skilled in strategy, team management, with strong interpersonal skills fostering customer happiness. MBA graduate with major in entrepreneurship. Private Investor and Board Member at Qubiotech Health Intelligence and ChemoSapiens

Nanoimmunotech is a nanobiotechnology Spanish SME with a wide knowledge in bioconjugation and biosensors. It was created in 2009 as a spin-off of two research centers with experience in different areas of nanobiotechnology. With venues in Zaragoza and Vigo, the company has great international presence, sells its products and services all over the world and cooperate in global R&D projects. With the purpose of becoming a world referent in nanobionsensors, they have launched to the market, HEATSENS®, a new disruptive technology of which the company has the exclusive patent and license.

UN-EM is a company created to advise Universities and Technological Centers to transfer research results to the market. The staff is specialized in technologies valuation, boosting entrepreneurship and the creation of Spin-Off companies. UN-EM facilitate the commercial exploitation of scientific results. The company is based on knowledge and methodologies which allows break down geographical barriers, with customers in Spain and Latin America.

The INL International Iberian Nanotechnology Laboratory, located in Braga (North of Portugal) was founded by the governments of Portugal and Spain under an international legal framework to perform interdisciplinary research, deploy and articulate nanotechnology for the benefit of society. INL aims to become the world-wide hub for nanotechnology addressing society’s grand challenges.

With more than 1,000 researchers dedicated to biotechnology and biomedicine, a Campus of International Excellence, CAMPUS VIDA, and 30 years of experience in valorization and transfer of research results, the USC has a portfolio of more than 200 patents and 40 spin-off based on the knowledge generated by its researchers.